IE20140129A1 - Dual and negative pressure wound therapy dressings for the prevention and management of tissue fluid, seroma and lymphoedema - Google Patents
Dual and negative pressure wound therapy dressings for the prevention and management of tissue fluid, seroma and lymphoedema Download PDFInfo
- Publication number
- IE20140129A1 IE20140129A1 IE20140129A IE20140129A IE20140129A1 IE 20140129 A1 IE20140129 A1 IE 20140129A1 IE 20140129 A IE20140129 A IE 20140129A IE 20140129 A IE20140129 A IE 20140129A IE 20140129 A1 IE20140129 A1 IE 20140129A1
- Authority
- IE
- Ireland
- Prior art keywords
- shape
- enclosure
- pressure
- appliance
- negative
- Prior art date
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 17
- 206010025282 Lymphoedema Diseases 0.000 title abstract description 14
- 208000002502 lymphedema Diseases 0.000 title abstract description 14
- 230000009977 dual effect Effects 0.000 title abstract description 7
- 206010040102 Seroma Diseases 0.000 title abstract description 4
- 230000002265 prevention Effects 0.000 title abstract description 4
- 238000009581 negative-pressure wound therapy Methods 0.000 title description 13
- 238000011282 treatment Methods 0.000 claims abstract description 18
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 15
- 210000002751 lymph Anatomy 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims description 11
- 210000000481 breast Anatomy 0.000 claims description 7
- 210000001099 axilla Anatomy 0.000 claims description 3
- 230000002829 reductive effect Effects 0.000 claims description 3
- 210000003141 lower extremity Anatomy 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims 1
- 210000003484 anatomy Anatomy 0.000 claims 1
- 210000004013 groin Anatomy 0.000 claims 1
- 230000037361 pathway Effects 0.000 claims 1
- 210000003899 penis Anatomy 0.000 claims 1
- 238000003825 pressing Methods 0.000 claims 1
- 210000004706 scrotum Anatomy 0.000 claims 1
- 238000007789 sealing Methods 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 206010052428 Wound Diseases 0.000 abstract description 21
- 208000027418 Wounds and injury Diseases 0.000 abstract description 21
- 210000001519 tissue Anatomy 0.000 abstract description 7
- 210000000746 body region Anatomy 0.000 abstract description 2
- 210000004907 gland Anatomy 0.000 abstract 1
- 230000001926 lymphatic effect Effects 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 102000003814 Interleukin-10 Human genes 0.000 description 3
- 108090000174 Interleukin-10 Proteins 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 229940076144 interleukin-10 Drugs 0.000 description 3
- 230000035168 lymphangiogenesis Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 108010073923 Vascular Endothelial Growth Factor C Proteins 0.000 description 2
- 102000009520 Vascular Endothelial Growth Factor C Human genes 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 239000002870 angiogenesis inducing agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000003511 endothelial effect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000001365 lymphatic vessel Anatomy 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 108010023728 Alloderm Proteins 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 102000004890 Interleukin-8 Human genes 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000906034 Orthops Species 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 1
- 101710088580 Stromal cell-derived factor 1 Proteins 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 108091008605 VEGF receptors Proteins 0.000 description 1
- 102000009524 Vascular Endothelial Growth Factor A Human genes 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 102000016663 Vascular Endothelial Growth Factor Receptor-3 Human genes 0.000 description 1
- 108010053100 Vascular Endothelial Growth Factor Receptor-3 Proteins 0.000 description 1
- 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 206010000583 acral lentiginous melanoma Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000003516 breast abscess Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 208000030381 cutaneous melanoma Diseases 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000036576 dermal application Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940096397 interleukin-8 Drugs 0.000 description 1
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000005073 lymphatic endothelial cell Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000007491 morphometric analysis Methods 0.000 description 1
- 230000030354 negative regulation of interleukin-12 production Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000012829 orthopaedic surgery Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 201000003708 skin melanoma Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 description 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 description 1
- 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000009724 venous congestion Effects 0.000 description 1
Landscapes
- Media Introduction/Drainage Providing Device (AREA)
- Surgical Instruments (AREA)
Abstract
The present invention relates to dual pressure therapy assisted dressings designed for, though not exclusively, to fit anatomical body contours which may overly any tissue containing fluid, lymph glands and lymphatics, for the treatment and prevention of lymphoedema, seroma and build up of tissue fluid. Specific dressing shapes designed to fit the contour of different body regions, either on the surface of the skin, enveloping the limb or appendage, or placed in body cavities or wounds and described in this invention. In some embodiments, the dressing provides an enclosure, some enveloping the portion of the body to be treated for purposes of applying in various modes and at different pressure, negative and or positive pressure therapy to that part of the body. <Figure 1>
Description
Title
Dual and Negative Pressure Wound Therapy Dressings for the Prevention and 5 Management of Tissue Fluid, Seroma and Lymphoedema.
Background
While it is almost 500 years since Asellius first described lymphatics in 1627, it is only recently that the importance of lymphatics and tissue fluid have been recognised. Lymphoedema is a very troublesome condition, difficult to treat and may arise for example, following surgery, in patients with tropical infections and following degenerative or congential diseases.
It has major social and economic impact globally and is associated with life limiting morbidity for those affected. It may increase the risk of cancer in the affected part of the body. Lymphoedema occurs following lymph node surgery in of between 10 and 30% of patients especially when performed in the axilla or inguinal region. Currently there are no known effective preventative and treatment regimens. Treatment including massage and manual compression are relatviley ineffective.
It is increasingly recognised that Negative Pressure Wound Therapy (NPWT) is beneficial in wound healing and fluid management (Moues.Bond). This effect is not confined to difficult or complex traumatic wounds. Evidence now exists that NPWT exerts beneficial effects on many wounds including elective closed incisions ( Blackam, Karlaki). This beneficial action is multifactoiral in origin, but alteration in wound’s biochemical milieu and fluid clearance appear to be fundamental to the effective mechanism NPWT (Oh).
Optimising outcomes is the foremost concern and any improvement in wound care with reduced risk of lymphoedema would be a great step forward. While negative pressure devices are commercially available they have not been adapted to treated the condition, as shown herein in this invention.
Key facilitators of the lymphatic regeneration are vascular endothelial growth fators, in particular VEGF-C and VEFG-D. These activate VEGF receptor which is expressed in the lymphatic endothelial cell. VEGFR-3 a tyrosine kinase inhibitor promotes lymphangiogenesis, generating new lymphatic vessels from pre-existing lymphatics or lymphatic endothelial progenitors. Gao and colleagues suggest that there is synergism in both angio and lymphangiesis especially between FGF-2 and VEGF-A and -C (Cao). These concepts are relatively new and in evolution.
Other physiological surfactants such as SDF-1 may play a role as well as fibroblast growth factor, platelet derived growth factor and many others. TGFp, interleukin 8, and interleukin 10 are produced and their role in lymphangiogenesis is umproven. ΤΟΕβ acts as an initiating substance in the in the cytokine reaction because it also contributes to upregulation of interleukin 10. Conversely, interleukin 10 and TGFp both stimulate each other in a positive feedback. Both cytokines are highly immunosuppressive and act through inhibition of interleukin-12 production from APCs.The role of NPWT has not been published in series of patients with lympoedema
NWPT exerts many actions, in particular promotions angiogenesis and lymphangiogenesis. NWPT appears to induce both morphologcial and quantitative alterations in lymph vessel networks in a wound (Labanaris). The combination of foam interface with NPT leads to mechanical microdeformations and resultant expression of angiogenic factors. NPWT may also remove inhibitory angiogenic factors such as matrix metalloproteinases. NWPT will increase VEGF (Kilpadi)
While NPWT has gained international acceptance in the treatment of certain conditions such as burns, open abdomen, difficult wounds, thee have been no reported tiral in of its use in lymphoedema. Current dressings available are not suitable for application in lymph bearing areas. In addition to promoting new lymphatic formation NPWT may also reduce wound seroma which are frequent following surgery. This invention will allow combinations of pressures applied through embodiments of dressings at various pressures and cycles with or without the incorporation of graduated pressure through combinations of positive and or negative pressure..
The addition of external graduated compression to this invention may further enhance the clincal efficacy of the invention
The invention will aid overcome the problems of lymphoedema,
Statement of Invention
100 In an embodiment of the present invention, a dual pressure, variable positive and negative treatment device including a flexible contoured dressing size, with or without additional external positive pressure dressing chamber in a contour to accomodate its application to body area. The advantage of the invention is that is will reduce lymphoedema and fluid and promote lymphatic generation and fluid transmision in the
105 tissue.
Brief description of the drawings
The various objects, advantages and features of this invention will be more apparent from a reading of the following detailed descriptionm, in conjunction with the included drawings, in which like reference numerals refer to like parts and in which;
Figure 1 is a frontal and lateral schematic view of a negative pressure wound therapy dressing being coupled to a negative pressure device through a conduit to an embodiment of the present invention. The pressure device may contain a collection reservoir or cannnester, which may be portable.
Figure 2 is a front and lateral perspective of a both positive and negative wound pressure dressings, which for the purpose of this invention may take any size, shape or from, to apply directly to skin, contour or wound. The chambers of each dressing are separate with the positive dressing enclosure on top of the negative therapy dressing.
Figure 3 is a perspective view of another embodiment of the dual pressure therapy dressing arrangment, which herein it is in a trouser shape designed for the lower abdomen, inguinal and upper thigh regions.
Figure 4 is a frontal view of another embodiment of potential arrangements of multiple interlinked dual postive and negative wound presssure therapy dressings .
Figure 5 is an anterior perspective of different embodiments and potential location of simple and complex arrangements of the dual or single positve or negative pressure therapy dressings.
Detailed Description Field of the Invention
The present invention relates generally to the field of medical devices and wound dressing, and more specifically to the field of treating and preventing lymphoedema and fluid build up.
The following statement is a full description of the invention and includes the best method of performing it. Numerous embodiments related to dermal application are disclosed herein. Further the embodiments disclosed herein relate to devices and dressing of variable size, form and consistency.
In accordance with the present invention a treatment dressing and pressure appliance is provided for treating all parts of the body with and without wounds
The invention relates particularly to a manner of use of variable pressure therapy in patients in any part of the body, limbs and torso.
This invention will have particular relevance in the management of fluid, healing of tissue and lymphoedema. The invention will treat patients with established lymphoedema and be used to manage patients with potential fluid and limb problems in the lymphatics in any part of the body. Through promotion of lymphatic generation it will prevent lymphoedema in high risk patients.
Currently there are no reported series of use of negative or positive or a combination of either as wound pressure therapy in the prevention and management of lymphoedema. This invention provides a flexible option for the dressing application to facilitate treatment. Referring now to illustrations and where the same features are denoted by common reference numerals.
Figure 1 shows a schematic section having an embodiment of the dressing according to the present invention applied over an area which may or may not contain lymphatics in the skin for the purpose of applying negative pressure therapy. The dressing is slightly elevated off the skin with the contact dressing sealed creating an enclosure. The contact layer 1 may be formed by perforated material and may contain different layers of various material and absorptive quality. The porous nature of the contact layer will allow pressure transmission to the underlying tissue and lymphatics and also permit fluid or exudate to pass from the skin 4 or wound bed. The contact layer may be made up different compound depending on the patient’s skin and clinical situation. The dressing has an aperture in the area on the top of the dressing. A valve is positioned with a flange in the aperture 5 and connected to a pressure generating source and canister 20, capable of generating either a negative or positive pressure by a connection tubing 3 or conduit and a cup shaped connection member having an aperture to accept the end of the pressure connection tube or conduit 3. The cupshaped member has a flange which rests on the upper surface of the dressing. A feature of this invention is the shape and form of this dressing placement relative to underlying lymphatic drainage. The tubing is then connected to the pressure device which may contain a collection device for fluid 20. An adhesive on a least a part of the under surface of the flange may be used to give a mechanism for affixing the vacuum port to the dressing contact layer. Any material may be used for the conduit or tubing to the pressure generator 3. The reservoir or collection canister may be formed of any type of contained which is suitable to hold fluid 20. The canister may contain absorptive material.
Referring to Figure 2 the dressing shown generally now included a second dressing 6 which in one embodiment has the second dressing applied on its superior surface of the negative pressure dressing 1. The second dressing 6 has a pressurized enclosure allowing through is port 5 and conduit 3 to the pressure device 20, the ability to deliver positive pressure. The pressure within the dressing may be gradated from minimal to maximal to create a tiered gradient across the dressing. This may be achieved by variable diameters and one way valve mechanisms I the confined space.
Referring to Figure 3 in one embodiment the dressing had been formed to take the shape of a body region contour 7, in this case the lower abdomen inguinal and upper thigh region. The dressing worn like a garment enveloped the area with a seals provided at the edge of the dressing.
Referring to Figure 4 there is coupling connection 8 in between single or multiple of either negative or positive dressings or combinations of the same, to provide a broader treatment area. . Any material may be used for the conduit or tubing between the dressings. The sealed dressing are interconnected with a conduits to permit
205 transfer of the pressure to great area. The channels or a plurality of longitudinal or transverse openings may permit the pressure to be applied to great areas. The dressing may be used over wound or incisions. In addition to the multiple dressings shown in Figure 4 serial and or parallel applications may be used. Some potential locations of these dressing are shown in Figure 5, 9 in the axilla, 10 the limb, 11 the abdomen and
210 12 lower limb.
215
References
Awad T, Butcher M. Handling the sequelae of breast cancer treatment: use of NPWT to enhance patient independence. J Wound Care. 2013 Mar;22(3):162, 164-6.
Blackham AU, Farrah Jp, McCoy TP Schmidt BS Shen P
Prevention of surgical infections in high risk patients with laparotomy incisions using negative pressure therapy Am J Surg 2013;205:647-654
Bonds AM, Novick TK, Dieted JB, Araghizadeh FY, Olson CH. Incisional negative pressure wound therapy significantly reduces surgical site infection in open colorectal surgery. Dis Colon Rectum. 2013;56(12):1403-1408.
Dian D, Bodungen V, Himsl I, Drinovac V, Myionas I, Sommer H, Friese K.
Worldwide first experiences with vacuum-assisted closure as alternative treatment method to repair defects of an extended thoracic wall recurrence of breast cancer. Arch Gynecol Obstet. 2010 May;281(5):927-32
Dustagheer S, Tohill M, Khan K. Vacuum-assisted closure dressing as an aid to salvage breast following severe postoperative infection. Breast J. 2009 Mar-Apr; 15(2):214-5
Erba P, Oawa R, Ackermann M et al Angiogenesis in wounds treated by microdeformational wound therapy Ann Surg 2011,253,402-409
Erba P, Rieger UM, Pierer G, Kalbermatten DF. Vacuum-assisted closure (VAC) for venous congestion of the nipple-areola complex. J Plast Reconstr Aesthet Surg. 2008 61(7):852-4
Karlakki S, Brem M, Giannini S, Khanduja V, Stannard J, Martin R. Negative pressure wound therapy for managementof the surgical incision in orthopaedic surgery: A review of evidence and mechanisms for an emerging indication. Bone Joint Res. 2013;2(12):276-84.
Kendrick AS, Chase CW. Salvage of an infected breast tissue expander with an implant sizer and negative pressure wound management. Plast Reconstr Surg. 2008;121(3):138e-139e.
Kilpadi DV, Cunningham MR (2011) Evaluation of closed incision management with negative pressure wound therapy (CIM): Hematoma/seroma and involvement of the lymphatic system. Wound Rep Reg 19: 588-96
Krumboeck A, Giovanoli P, Plock JA (2013) Fat grafting and stem cell enhanced fat grafting to the breast under oncological aspects-Recommendations for patient selection. The Breast 2013;1-6
Labler L Rancan M Ladislav Mica L Luc Harter L Daniela Mihic-Probst D
Keel M Vacuum-Assisted Closure Therapy Increases Local lnterleukin-8 and Vascular Endothelial Growth Factor Levels in Traumatic Wounds J Trauma. 2009; 66:749-757.
Liao EC, Breuing KH (2007) Breast mound salvage using vacuum-assisted closure device as bridge to reconstruction with inferolateral AlloDerm hammock. Annals of Plastic Surgery 59: 218-224
A, Dittmer C, Diedrich K, Thill M Successful application of vacuum-assisted closure therapy for treatment of mastitis-associated chronic breast wounds. Archives of Gynecology and Obstetrics 283: 1357-1362
Meeker J, Weinhold P, Dahners L (2011) Negative pressure therapy on primarily closed wounds improves wound healing parameters at 3 days in a porcine model. J Orthop Trauma 25: 756-761
Mohammed RA, Ellis IO, Elsheikh S, Paish EC, Martin SG (2007) Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications. Breast Cancer Res Treat 113:261-273
Moues CM Heule F Hovius S. E. R A review of topical negative pressure therapy in wound healing: sufficient evidence? Am J Surg 2011 201, 544-556
Oh BH Lee SH,Nam KA Lee HB Chung KY Comparison of negative pressure wound therapy and secondary intention healing after excision of acral lentiginous melanoma on the foot Brit J Dermatol 2013 168, 333-338
Pavlista D, Eliska O (2012) Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla-A lesson from the past-Contribution to the concept of axillary reverse mapping. EJSO 38: 390-394
Raff I AB. The use of negative pressure under skin flaps after radical
Mastectomy. Ann Surg. 1952 Dec;136(6):1048
Ricci WM, Gardener M, Jo M, McAndrew C (2012) What’s new in orthopaedic trauma J Bone Joint Surg Am 94: 1525-35
Richards AJ, Hagelstein SM, Patel GK, Ivins NM, Sweetland HM, Harding KG.
Early use of negative pressure therapy in combination with silver dressings in a difficult breast abscess. Int Wound J. 2011 Dec;8(6):608-11
Stoeckel WT, David L, Levine EA, Argenta AE, Perrier ND (2006) Vacuum-assisted closure for the treatment of complex breast wounds. The Breast 15: 610-613
Stolier A, Skinner J (2000) A prospective study of seeding of the skin after core biopsy of the breast. Am J Surg 180: 104-107
Storr SJ, Safuan S, Mitra A, Elliott F, Walker C, Vasko MJ, Ho B, Cook M, Mohammed RA, Patel PM, Ellis IO, Newton-Bishop JA, Martin SG Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma. (2012) Modern Pathology 25: 493-504
Claims (22)
1 . A device for the application and administration of variable, both positive and negative or a combination of both pressures through a dressing that can be applied to any part of the body as treatment in mammals, comprising: of a dressing chamber, or chambers, to include an inner surface, an outer surface, and a sealing portion that creates an isolated treatment space, the chamber being made of a flexible impermeable material, placed on top or separately; (Figure 1, Figure 2)) a plurality of material on the inner surface side, with the embossed structures defining a concave shape relative to the outer surface, the structures deigned to directly contact the surface of the skin and or wound and deigned to allow pressure to be applied and maintained in the isolated treatment space, the plurality of structures intruding from the inner surface of the chamber into the isolated treatment space; wherein all of the pathways for distributing either negative or positive pressure are between the inner surface and the skin and wound and the second chamber positioned if wished on the first chamber being made of a flexible impermeable material; (Figure 1) A plurality of material on the inner surface side; and a tube multiple tubing or conduit connected to the either chamber, via a port or sealed connection, the tube being in flexible connection, with the isolated treatment spaces so as to enable at least one selected from the group of applying pressure to the treatment space and using as a therapeutic modality
2. . The device of claim 1, wherein the plurality of structures are arranged in patterns to define a channel on the inner surface of the chamber
3. , The device of claim 2, wherein the plurality of structures intrudes into the isolated treatment space in a direction generally perpendicular to the inner surface
4. . The device of claim 3, wherein each embossed structure has a shape selected, variable in size, malleable and flexible, rectangular, square, folding parallel rectangles, a pyramid, a pentagon, a hexagon, a half sphere, a dome, a rod, an elongated shape to fit all skin crease shapes with square sides
5. . The device of claim 4, wherein the shape has the same shape as external body part to be enclosed (Figure 3)
6. . The device of claim 5, wherein the shape has the same shape as lower limb
7. The device of claim 6, wherein the shape has the same shape as groin crease
8. The device of claim 7, wherein the shape has the same shape as axilla
9. The device of claim 8, wherein the shape has the same shape as lower torso
10. The device of claim 9, wherein the shape has the same shape as the hand
11. The device of claim 10, wherein the shape has the same shape as the breast
12. The device of claim 11, wherein the shape has the same shape as the penis
13. The device of claim 12, wherein the shape has the same shape as scrotum
14. The device of claim 13, wherein the shape has the same shape as the neck and supraclavicular fossa and fashioned according the individuals skin and skin crease anatomy
15. An appliance for creating and administering negative, reduced or positive pressure, or combination of pressure, either in cycles or constantly, for treatment to part of the body, the appliance comprising of; An enclosure consisting of a malleable flexible material and a port, wherein the enclosure has an opening and a confined volume adjacent to the opening and the enclosure is sized and positioned over and encloses the part of the body or cavity to be treated and the enclosure is managed to allow reduced negative pressure under the enclosure, with an outer enclosure allowing alternative pressure to applied be this position of negative, wherein part or all of the enclose will form the shape of the external skin or cavity contours, when negative or positive pressure or combinations and variations of pressure are applied, with the tubing and controls set to facilitate the flow of fluid and lymph from the portion of the body to be treated, the wound interface material is separate from the enclosure; A seal to functionally create the enclosure to the external part about the opening and wherein the seal is shaped and made to maintain the applied pressure and Wherein the port is attached to the generator device for negative or positive pressure to supply the pressure therapy
16. The appliance of claim 15, wherein: The flow and pressure control is operably connected to the port and the flow control permits variable fluid and lymph to flow under the single or multiple enclosures
17. An appliance claim of 16, with the addition of flow control by variable pressure in the continuity of the tube and the external vacuum or positive pressure pump.
18. The appliance of claim 17 wherein the port is located adjacent to the opening of the enclosure
19. The appliance of claim 18 wherein the port is located adjacent to the middle of the enclosure (figure 2)
20. The appliance of claim 19 wherein there are multiple ports located over the enclosure
21. The appliance of claim 20 wherein there are multiple ports located over the enclosure and the dressings are applied in different locations and directions or in combination.
22. The appliance of claim 20 wherein there are multiple ports located over the enclosure and the dressing’s enclosure are linked (figure 4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE20140129A IE86941B1 (en) | 2014-05-27 | 2014-05-27 | Dual and negative pressure wound therapy dressings for the prevention and management of tissue fluid, seroma and lymphoedema |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE20140129A IE86941B1 (en) | 2014-05-27 | 2014-05-27 | Dual and negative pressure wound therapy dressings for the prevention and management of tissue fluid, seroma and lymphoedema |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE20140129A1 true IE20140129A1 (en) | 2016-03-23 |
| IE86941B1 IE86941B1 (en) | 2018-12-12 |
Family
ID=55759401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE20140129A IE86941B1 (en) | 2014-05-27 | 2014-05-27 | Dual and negative pressure wound therapy dressings for the prevention and management of tissue fluid, seroma and lymphoedema |
Country Status (1)
| Country | Link |
|---|---|
| IE (1) | IE86941B1 (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10575991B2 (en) | 2015-12-15 | 2020-03-03 | University Of Massachusetts | Negative pressure wound closure devices and methods |
| US10814049B2 (en) | 2015-12-15 | 2020-10-27 | University Of Massachusetts | Negative pressure wound closure devices and methods |
| US11083631B2 (en) | 2012-07-16 | 2021-08-10 | University Of Massachusetts | Negative pressure wound closure device |
| US11166726B2 (en) | 2011-02-04 | 2021-11-09 | University Of Massachusetts | Negative pressure wound closure device |
| US11241337B2 (en) | 2012-05-24 | 2022-02-08 | Smith & Nephew, Inc. | Devices and methods for treating and closing wounds with negative pressure |
| US11419767B2 (en) | 2013-03-13 | 2022-08-23 | University Of Massachusetts | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
| US11439539B2 (en) | 2015-04-29 | 2022-09-13 | University Of Massachusetts | Negative pressure wound closure device |
| US11471586B2 (en) | 2015-12-15 | 2022-10-18 | University Of Massachusetts | Negative pressure wound closure devices and methods |
| US12133790B2 (en) | 2013-10-21 | 2024-11-05 | Smith & Nephew, Inc. | Negative pressure wound closure device |
-
2014
- 2014-05-27 IE IE20140129A patent/IE86941B1/en not_active IP Right Cessation
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11166726B2 (en) | 2011-02-04 | 2021-11-09 | University Of Massachusetts | Negative pressure wound closure device |
| US11241337B2 (en) | 2012-05-24 | 2022-02-08 | Smith & Nephew, Inc. | Devices and methods for treating and closing wounds with negative pressure |
| US11083631B2 (en) | 2012-07-16 | 2021-08-10 | University Of Massachusetts | Negative pressure wound closure device |
| US11564843B2 (en) | 2012-07-16 | 2023-01-31 | University Of Massachusetts | Negative pressure wound closure device |
| US11419767B2 (en) | 2013-03-13 | 2022-08-23 | University Of Massachusetts | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
| US12133790B2 (en) | 2013-10-21 | 2024-11-05 | Smith & Nephew, Inc. | Negative pressure wound closure device |
| US12239509B2 (en) | 2013-10-21 | 2025-03-04 | Smith & Nephew, Inc. | Negative pressure wound closure device |
| US11439539B2 (en) | 2015-04-29 | 2022-09-13 | University Of Massachusetts | Negative pressure wound closure device |
| US10575991B2 (en) | 2015-12-15 | 2020-03-03 | University Of Massachusetts | Negative pressure wound closure devices and methods |
| US10814049B2 (en) | 2015-12-15 | 2020-10-27 | University Of Massachusetts | Negative pressure wound closure devices and methods |
| US11471586B2 (en) | 2015-12-15 | 2022-10-18 | University Of Massachusetts | Negative pressure wound closure devices and methods |
Also Published As
| Publication number | Publication date |
|---|---|
| IE86941B1 (en) | 2018-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE20140129A1 (en) | Dual and negative pressure wound therapy dressings for the prevention and management of tissue fluid, seroma and lymphoedema | |
| Lancerotto et al. | Mechanisms of action of microdeformational wound therapy | |
| Lalezari et al. | Deconstructing negative pressure wound therapy | |
| Banwell et al. | Topical negative pressure (TNP): the evolution of a novel wound therapy | |
| Banwell | Topical negative pressure therapy in wound care | |
| Serra et al. | Skin grafting for the treatment of chronic leg ulcers–a systematic review in evidence‐based medicine | |
| Richmand et al. | Sequential pneumatic compression for lymphedema: a controlled trial | |
| Wu et al. | Vacuum therapy as an intermediate phase in wound closure: a clinical experience | |
| Dhir et al. | Vacuum‐assisted closure therapy in the management of head and neck wounds | |
| US20100274177A1 (en) | Pulsed electromagnetic field and negative pressure therapy wound treatment method and system | |
| Marola et al. | Management of venous ulcers: State of the art | |
| RU2013154702A (en) | FABRIC HEALING | |
| CN204581655U (en) | Medical cold is applied ointment or plaster | |
| CN111686152A (en) | External composition and gel for treating lymphedema and preparation method thereof | |
| CN204193129U (en) | A kind of compound Folium Artemisiae Argyi sanitary towel | |
| Siddha et al. | Efficacy of modifi ed vacuum assisted closure in wound healing | |
| CN204468433U (en) | A kind of water proof type postoperative wound magnetic therapy applying plaster | |
| Bi et al. | Ultrasound-guided scraping of fibrous capsule plus bilayered negative pressure wound therapy for treatment of refractory postmastectomy seroma | |
| Tan et al. | Lower gluteal muscle flap and buttock fascio-cutaneous rotation flap for reconstruction of perineal defects after abdomino-perineal resections | |
| Pyo et al. | Vaccum-assisted closure therapy in split-thickness skin graft on the wound on the contours of the body | |
| Joshi et al. | Application of Negative Pressure Wound Therapy on Closed | |
| Alvarez et al. | A novel treatment for venous leg ulcers | |
| CN1256966C (en) | Traditional Chinese medicinal ointment for treaing burns and scald, and its prepn. method | |
| Lee et al. | Negative pressure wound therapy applied to a meshed split-thickness skin graft | |
| Thomas et al. | Topical negative-pressure therapy in wound management |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |